Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.

ABSTRACT: We identified fibro-inflammatory and keratin gene expression signatures in systemic sclerosis skin.

ORGANISM(S): Homo sapiens

PROVIDER: GSE58095 | GEO | 2015/05/26

SECONDARY ACCESSION(S): PRJNA248898

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.

Project description:We identified fibro-inflammatory and keratin gene expression signatures in systemic sclerosis skin. Skin biopsy samples from 61 patients enrolled in the GENISOS cohort or an open label imatinib study (baseline sample) and 36 controls were examined by global gene expression studies. 5 patients were sampled at two time points (early-late). There is overlap between this data set and GSE47162.

2015-05-26 | E-GEOD-58095 | biostudies-arrayexpress

Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.

Project description: Not available

| S-EPMC5394431 | biostudies-literature

IL-1 inhibition in systemic sclerosis skin.

Project description:IL-1 inhibition in systemic sclerosis skin.

| PRJNA490744 | ENA

Expression data from skin biopsies in patients with systemic sclerosis

Project description:We used microarrays to explore gene expression in Systemic Sclerosis patients.

2018-01-02 | GSE95065 | GEO

Expression data from skin biopsies in pateints with systemic sclerosis treated with anti-TGF-beta, fresolimumab

Project description:Systemic sclerosis is associated with skin fibrosis thought mediated by TGFb. This open label clinical trial examines the effect of TGFb inhibition on skin gene expression. Patients 1-9 received two doses 1 mg/kg dose of fresolimumab at baseline and 3 weeks; patients 10-19 received a single 5 mg/kg dose Patients with diffuse cutaneous systemic sclerosis within 2 years of first raynauds had skin biopsies before treatment and the 3-4 weeks, 7 weeks and 24 weeks after treatment with fresolimumab

2015-06-05 | E-GEOD-55036 | biostudies-arrayexpress

Skin biopsy expression from the faSScinate phase 2 study of tocilizumab in systemic sclerosis

Project description:Gene expression profiling via microarray was performed for control donors and systemic sclerosis (SSc) patients.

2023-12-10 | GSE249550 | GEO

Gene expression from human keratinocytes isolated from limited systemic sclerosis (lcSSc) and diffuse systemic sclerosis (dcSSc) skin biopsy

Project description:Systemic sclerosis (SSc) is a rare but devastating disease of fibrosis impacting the dermis and multiple organ systems. The prevalence ranges from 4 to 489 cases per million individuals with ten year mortality rates reported around 18 percent. Survival is related to the extent of skin involvement, yet the precise mechanisms driving skin fibrosis in SSc remain unknown. In this study, we analyzed the shared and unique transcriptomic profiles of SSc and normal keratinocytes.

2018-03-21 | GSE81072 | GEO

Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis

Project description:We identified eighty two skin transcripts significantly correlated with the severity of interstitial lung disease (ILD) in systemic sclerosis. These genes separated patients with more sever ILD in unsupervised hierarchical clustering. Pathway analysis revealed pathways involved in extravasation and adhesion of inflammatory cells to endothelium. Skin biopsy samples from 59 patients enrolled in the GENISOS cohort or an open label imatinib study were examined by global gene expression studies.

2013-07-12 | E-GEOD-47162 | biostudies-arrayexpress

DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma

Project description:DNA methylation patterns in juvenile systemic sclerosis and localized scleroderma

| PRJNA732196 | ENA

Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis

2013-07-12 | GSE47162 | GEO